<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03713255</url>
  </required_header>
  <id_info>
    <org_study_id>20180259-01H</org_study_id>
    <nct_id>NCT03713255</nct_id>
  </id_info>
  <brief_title>Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial</brief_title>
  <official_title>Analgesic Benefits of the Novel Mid-point Transverse Process to Pleura (MTP) Block for Ambulatory Breast Cancer Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the analgesic effects of midpoint transverse process to pleura (MTP)&#xD;
      block to control as well as thoracic paravertebral block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Paravertebral blocks (PVBs) are frequently used for regional anesthesia for breast surgery.&#xD;
      Ultrasound-guided paravertebral block is an advanced skill. The needle tip can be difficult&#xD;
      to visualize with ultrasound, and the proximity to neurovascular structures as well as the&#xD;
      pleura presents a risk of neurovascular injection and pneumothorax respectively. The midpoint&#xD;
      transverse-process to pleura (MTP) block incorporates a novel needle endpoint that is&#xD;
      technically easier to achieve and more distant from neurovascular structures and the pleura&#xD;
      compared to traditional PVB. This study will compare the analgesic effects of MTP block to&#xD;
      control and PVB.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized, quadruple-blinded, three arm parallel group clinical trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Quadruple (participant, care provider, investigator, outcomes assessor)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative analgesia during the first 24 hours.</measure>
    <time_frame>48 hours</time_frame>
    <description>Measured by opioid (equivalents of morphine) consumption and pain scores on a numerical rating scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative quality of recovery during the first 24 hours.</measure>
    <time_frame>48 hours</time_frame>
    <description>Measured by the Quality of recovery (QoR-15 scale).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Acute Pain</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>PVB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>paravertebral blocks with 0.5% ropivacaine and epinephrine 2.5 mcg/mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MTP block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MTP blocks with 0.5% ropivacaine and epinephrine 2.5 mcg/mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>local anesthetic infiltration subcutaneous 1% lidocaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PVB group</intervention_name>
    <description>Patients in this group will receive preoperative ultrasound-guided thoracic paravertebral block using ropivacaine 0.5% with epinephrine 2.5 mcg/mL, and supplemental standardized anesthetic/analgesic regimen (Acetaminophen / NSAIDs / opioids for breakthrough pain).</description>
    <arm_group_label>PVB group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MTP block group</intervention_name>
    <description>Patients in this group will receive preoperative ultrasound-guided mid-point transverse process to pleura block using ropivacaine 0.5% with epinephrine 2.5 mcg/mL, and supplemental standardized anesthetic/analgesic regimen (Acetaminophen / NSAIDs / opioids for breakthrough pain).</description>
    <arm_group_label>MTP block group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>Patients in this group will receive preoperative ultrasound-guided sham block with subcutaneous local anesthetic injection using lidocaine 1%, and supplemental standardized anesthetic/analgesic regimen (Acetaminophen / NSAIDs / opioids for breakthrough pain).</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English or French Speaking&#xD;
&#xD;
          -  Scheduled for major breast surgery&#xD;
&#xD;
          -  ASA physical status classification I-III&#xD;
&#xD;
          -  BMI &lt;30kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior ipsilateral breast surgery&#xD;
&#xD;
          -  Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral&#xD;
             chest&#xD;
&#xD;
          -  Contraindications to regional anesthesia&#xD;
&#xD;
          -  Patient refusal of regional technique&#xD;
&#xD;
          -  Chronic pain disorder&#xD;
&#xD;
          -  Chronic opioid use&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioana Costache, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Hospital, Ottawa Hospital Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ioana Costache, MD</last_name>
    <phone>(613) 737-8187</phone>
    <email>icostache@toh.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioana Costache, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 27, 2018</study_first_submitted>
  <study_first_submitted_qc>October 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Paravertebral Block</keyword>
  <keyword>Breast Cancer Surgery</keyword>
  <keyword>MTP block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

